Evidence map›Paper›PMID 30201051›Full record

ArticleOrphanet journal of rare diseases2018

TSC-associated neuropsychiatric disorders (TAND): findings from the TOSCA natural history study.

Petrus J de Vries, Elena Belousova, Mirjana P Benedik, Tom Carter, Vincent Cottin, Paolo Curatolo, Maria Dahlin, Lisa D'Amato, Guillaume B d'Augères, José C Ferreira and 20 more

Open access · goldAbstract read
In one paragraph

Article in Orphanet journal of rare diseases, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 87 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
87citing papers in PubMed, 4 pooled it
12.6field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

87 citing papers in PubMed, 4 syntheses or guidelines pooled it, 185 citations in OpenAlex.

  1. Tuberous sclerosis-associated psychosis: a systematic review.Journal of neural transmission (Vienna, Austria : 1996) · 2026
    Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Trial
  6. Trial
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Tuberous sclerosis complex.Nature reviews. Disease primers · 2026
    Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review

27 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

30 authors at 20 institutions in 20 countries.

Petrus J de VriesDivision of Child and Adolescent Psychiatry, University of Cape Town, 46 Sawkins Road, Rondebosch, Cape Town, 7700, South Africa. petrus.devries@uct.ac.za.
Elena BelousovaResearch and Clinical Institute of Pediatrics, Pirogov Russian National Research Medical University, Moscow, Russian Federation.
Mirjana P BenedikSPS Pediatrična Klinika, Ljubljana, Slovenia.
Tom CarterTSA Tuberous Sclerosis Association, Nottingham, UK.
Vincent CottinHôpital Louis Pradel, Claude Bernard University Lyon 1, Lyon, France.
Paolo CuratoloTor Vergata University Hospital, Rome, Italy.
Maria DahlinKarolinska University Hospital, Stockholm, Sweden.
Lisa D'AmatoNovartis Farma S.p.A, Origgio, Italy.
Guillaume B d'AugèresAssociation Sclérose Tubéreuse de Bourneville, Gradignan, France.
José C FerreiraCentro Hospitalar Lisboa Ocidental, Lisbon, Portugal.
Martha FeuchtUniversitätsklinik für Kinder-und Jugendheilkunde, Vienna, Austria.
Carla FladrowskiAssociazione Sclerosi Tuberosa ONLUS, Milan, Italy.
Christoph HertzbergVivantes-Klinikum Neukölln, Berlin, Germany.
Sergiusz JozwiakDepartment of Child Neurology, Warsaw Medical University, Warsaw, Poland.
J Chris KingswoodSussex Kidney Unit, Royal Sussex County Hospital, Brighton, UK.
John A LawsonThe Tuberous Sclerosis Multidisciplinary Management Clinic, Sydney Children's Hospital, Randwick, NSW, Australia.
Alfons MacayaHospital Universitari Vall d'Hebron, Barcelona, Spain.
Ruben MarquesNovartis Farma S.p.A, Origgio, Italy.
Rima NabboutDepartment of Pediatric Neurology, Necker Enfants Malades Hospital, Paris Descartes University, Paris, France.
Finbar O'CallaghanInstitute of Child Health, University College London, London, UK.
Jiong QinDepartment of Pediatrics, Peking University People's Hospital (PKUPH), Beijing, China.
Valentin SanderTallinn Children Hospital, Tallinn, Estonia.
Matthias SauterKlinikverbund Kempten-Oberallgäu gGmbH, Kempten, Germany.
Seema ShahNovartis Healthcare Pvt. Ltd, Hyderabad, India.
Yukitoshi TakahashiNational Epilepsy Center, Shizuoka Institute of Epilepsy and Neurological Disorders, NHO, 886 Urushiyama, Aoi-ku, Shizuoka, Japan.
Renaud TouraineHôpital Nord, Saint Etienne, France.
Sotiris Youroukos"St. Sophia" Children's Hospital, Athens, Greece.
Bernard ZonnenbergUniversity Medical Center, Utrecht, The Netherlands.
Anna C JansenUZ Brussel Vrije Universiteit Brussel, Brussels, Belgium.
TOSCA Consortium and TOSCA Investigators
Associazione Italiana Sclerosi Multipla · ITCentro Hospitalar de Lisboa Ocidental · PTChildren's Hospital Agia Sophia · GRHôpital Necker-Enfants Malades · FRHôpital Nord · FRKarolinska University Hospital · SEKempten University of Applied Sciences · DEMedical University of Warsaw · PLNational Epilepsy Center · JPNovartis (India) · INNovartis (Italy) · ITOčesna Klinika UKC Ljubljana · SIPeking University · CNPirogov Russian National Research Medical University · RURoyal Sussex County Hospital · GBSydney Children's Hospital · AUTallinn Health Care College · EETuberous Sclerosis Association · GBUniversidad de León · ESUniversitätsklinik für Kinder und Jugendpsychiatrie · AT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundMost evidence for TSC-associated neuropsychiatric disorders (TAND) to date have come from small studies and case reports, and very little is known about TAND in adults. We explored baseline TAND data from the large-scale international TOSCA natural history study to compare childhood and adult patterns, describe age-based patterns, and explore genotype-TAND correlations.

resultsThe study enrolled 2216 eligible participants with TSC from 170 sites across 31 countries at the data cut-off for the third interim analysis (data cut-off date: September 30, 2015). The most common behavioural problems (reported in > 10% of participants) were overactivity, sleep difficulties, impulsivity, anxiety, mood swings, severe aggression, depressed mood, self-injury, and obsessions. Psychiatric disorders included autism spectrum disorder (ASD, 21.1%), attention deficit hyperactivity disorder (ADHD, 19.1%), anxiety disorder (9.7%), and depressive disorder (6.1%). Intelligence quotient (IQ) scores were available for 885 participants. Of these, 44.4% had normal IQ, while mild, moderate, severe, and profound degrees of intellectual disability (ID) were observed in 28.1, 15.1, 9.3, and 3.1%, respectively. Academic difficulties were identified in 58.6% of participants, and neuropsychological deficits (performance <5th percentile) in 55.7%. Significantly higher rates of overactivity and impulsivity were observed in children and higher rates of anxiety, depressed mood, mood swings, obsessions, psychosis and hallucinations were observed in adults. Genotype-TAND correlations showed a higher frequency of self-injury, ASD, academic difficulties and neuropsychological deficits in TSC2. Those with no mutations identified (NMI) showed a mixed pattern of TAND manifestations. Children and those with TSC2 had significantly higher rates of intellectual disability, suggesting that age and genotype comparisons should be interpreted with caution.

conclusionsThese results emphasize the magnitude of TAND in TSC and the importance of evaluating for neuropsychiatric comorbidity in all children and adults with TSC, across TSC1 and TSC2 genotypes, as well as in those with no mutations identified. However, the high rates of unreported or missing TAND data in this study underline the fact that, even in expert centres, TAND remains underdiagnosed and potentially undertreated.

Indexed as

AdolescentAdultAnxiety DisordersAttention Deficit Disorder with HyperactivityAutism Spectrum DisorderChildChild, PreschoolDepressive DisorderFemaleGenotypeHumansIntellectual DisabilityMaleMutationNeuropsychological TestsTuberous SclerosisTSC1 protein, humanTSC2 protein, humanTuberous Sclerosis Complex 1 ProteinTuberous Sclerosis Complex 2 ProteinTOSCATSC-associated neuropsychiatric disordersTuberous sclerosis complex

Identifiers

PMID30201051
PMCPMC6131901
OpenAlexW2890093841

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.